Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Senti Bio Enters Collaboration with Spark Therapeutics to Develop Next-Generation Precision Gene Therapies
Wednesday, April 14, 2021Senti Biosciences a leading gene circuit company announced a collaboration and option agreement with Spark Therapeutics a member of the Roche Group to apply Senti Bios gene circuit technology to the development of nextgeneration precision gene therap...
Spark Therapeutics Enters Collaboration with Senti Bio to Bolster Industry-Leading Gene Therapy Research Platform
Wednesday, April 14, 2021Spark Therapeutics a member of the Roche Group and a fully integrated commercial gene therapy company dedicated to challenging the inevitability of genetic disease today announced a collaboration and option agreement with Senti Biosciences
Antengene Announces First Patient Dosed in Phase II Trial of ATG-008 (Onatasertib) in Patients with Advanced Solid Tumors with Specific Genetic Alterations
Monday, April 12, 2021Antengene Corporation Limited a leading innovative biopharmaceutical company dedicated to discovering developing and commercializing global firstinclass andor bestinclass therapeutics in hematology and oncology
HEC Pharm Selects ABEC Large-Scale Fermenters to Increase Biopharmaceutical Production Capacity
Monday, April 12, 2021ABEC a global provider of integrated solutions and services for biopharmaceutical manufacturing announced it will design manufacture and install multiple L fermenter trains for HEC Pharms manufacturing site in Guangzhou China
Celcuity Announces Worldwide Licensing Agreement with Pfizer to Develop and Commercialize Gedatolisib, a First-in-Class PI3K/mTOR Inhibitor for Breast Cancer
Friday, April 09, 2021Celcuity Inc a clinicalstage biotechnology company pursuing an integrated companion diagnostic and therapeutic strategy for treating patients with cancer today announced it has entered into a global licensing agreement with Pfizer Incgranting Celcuit...
Context Therapeutics and Integral Molecular Enter Collaboration and License Deal for Novel Claudin 6 Antibodies for Gynecologic Cancer Therapeutic Program
Friday, April 09, 2021Context Therapeutics a clinicalstage womens oncology company developing advanced small molecule and immunotherapy treatments to transform care for hormonedriven breast and gynecological cancers
Shanghai Genechem Co., Ltd. (Genechem) announces global collaboration on bispecific antibodies
Thursday, April 08, 2021Shanghai Genechem Co Ltd Genechem a discovery company dedicated to the discovery of new drug targets and the development of new therapeutic products today announced the conclusion of a global collaboration with IMab
Progenity and Ionis Pharmaceuticals Enter into Agreement to Evaluate Progenity’s Ingestible Oral Biotherapeutics Technology for Delivery of Antisense Therapies
Thursday, April 08, 2021Progenity Inc a biotechnology company with an established track record of success developing and commercializing molecular testing products today announced an agreement with Ionis Pharmaceuticals the leader in RNAtargeted therapeutics to evaluate the...
Hadassah and MyBiotics to Collaborate for the Discovery of Microbiome-Based Therapy for Improving Cancer Immunotherapy
Thursday, April 08, 2021MyBiotics Pharma Ltd a microbiome therapeutics company and Hadasit Medical Research Services and Development Ltd the technology transfer office of Hadassah Medical Center announced that they have entered into a research collaboration and licensing ag...
Cidara Therapeutics Announces Agreement with Janssen to Develop and Commercialize AVCs for the Prevention and Treatment of Influenza
Tuesday, April 06, 2021Cidara Therapeutics Inc a biotechnology company developing longacting therapeutics designed to transform the standard of care for patients facing serious fungal or viral infections announced that it has entered into an exclusive worldwide license and...
